Using indocyanine green to find sentinel lymph nodes during mastectomy
Official title: Indocyanine Green Guided Identification of Sentinel Lymph Nodes Via Mastectomy Incision in Breast Cancer Patients (INIGMA Study)
Run by St. Antonius Hospital · NCT07362485 · Data updated 2026-11-12
This pilot will test whether injecting indocyanine green and using fluorescence during mastectomy can find sentinel lymph nodes in women with clinically node-negative invasive breast cancer.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | Women only |
| Enrollment | 90 (estimated) |
| Sponsor | St. Antonius Hospital Academic / other |
| Locations | 2 sites (Zwolle, Overijssel and 1 other locations) |
| Status | Recruiting |
| Started | August 22, 2022 |
| Main results expected | April 2026 |
| Study ends | June 2026 |
| Registry record updated | January 23, 2026 |
| Trial ID | NCT07362485 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Women with biopsy-proven, clinically node-negative invasive T1–T3 breast cancer who are scheduled for mastectomy with a sentinel node procedure and can give informed consent are eligible.
✕Probably not a fit
Patients planning breast-conserving surgery, immediate reconstruction, with known allergy to ICG or technetium, with other concurrent solid tumors, or with clinically node-positive disease are unlikely to benefit from this approach.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This multicenter pilot enrolls women with clinically node-negative, invasive T1–T3 breast cancer who are having a mastectomy with a sentinel lymph node procedure at St. Antonius or Isala Hospital. All participants receive the standard preoperative 99mTc injection, then 5 mg of indocyanine green (ICG) after anesthesia, and surgeons search for fluorescent sentinel nodes through the mastectomy incision without making a separate axillary cut. The primary outcome is the ICG detection rate of sentinel lymph nodes via the mastectomy incision. Secondary outcomes compare ICG with 99mTc detection, number and concordance of nodes found, pathology differences, detection time, and complications.
Why it matters
Potential benefit: If successful, the technique could allow surgeons to locate sentinel nodes through the mastectomy incision without an extra axillary incision, potentially reducing additional incisions and operative burden.
How similar studies have gone: ICG-fluorescence for SLNB via a dedicated axillary incision has shown good diagnostic performance in prior work and is used clinically, but using only the mastectomy incision for ICG-guided detection is novel and not well described.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Clinically node-negative, DCIS, invasive T1- T3 breast cancer confirmed by biopsy. * Preoperative axillary ultrasound to confirm clinical node-negative status. * Indication (or preference) for mastectomy and simultaneous SLN procedure. * Written informed consent according to ICH/GCP and national regulations. Exclusion Criteria: * Patients \< 18 years old * Breast conserving surgery * Direct reconstruction (with autologous tissue or implant) * Known allergy for indocyanine green (ICG) or radioisotope technetium (99mTc), intravenous contrast or iodine * Other concurrent solid tumour * Hyperthyroidism or thyroid cancer * Pregnancy or breast feeding * Psychological, familial, sociological or geographical factors that could potentially hamper compliance with the study protocol
Where it's running
-
Isala
Zwolle, Overijssel, Netherlands Recruiting -
St. Antonius Ziekenhuis
Utrecht, Utrecht, Netherlands Recruiting
Study contacts
- Study coordinator: Isabelle Henskens, MD
- Email: i.henskens@antoniusziekenhuis.nl
- Phone: +31883202902
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Using indocyanine green to identify sentinel lymph nodes during breast cancer surgery
This project tests whether indocyanine green dye and a fluorescence camera can be used instead of the radioactive tracer to find sentinel lymph nodes in adults having breast cancer surgery who are clinically node-negative.
-
Combined PECS II and PIP blocks vs TPVB for post-mastectomy pain relief
This trial tests whether a combination of PECS II and superficial PIP blocks can provide better or similar pain relief after mastectomy compared with the standard thoracic paravertebral block.
-
Same-day awake mastectomy with immediate prepectoral implant reconstruction
This project tests whether the AMADeuS care pathway—awake same-day mastectomy with prepectoral implant reconstruction, opioid-sparing anesthesia, and telemedicine follow-up—controls pain and is as safe as usual hospital care for women having mastectomy.
-
Fast detection of cancer in sentinel lymph nodes using a new NIR-II fluorescent probe.
This test applies a new near-infrared (NIR-II) fluorescent probe to freshly removed sentinel lymph nodes to quickly tell adults with breast cancer whether the cancer has spread there.
-
Targeted sentinel node biopsy for breast cancer patients with limited axillary nodal disease
This audit will test if removing the marked node along with the sentinel nodes can identify people with only 1–2 positive axillary nodes so some can avoid a full axillary dissection, for adults with cT1-2 breast cancer and biopsy-proven axillary metastases with no more than two abnormal nodes on imaging.
-
Using advanced imaging technology for early-stage breast cancer surgery
This study is testing a new imaging tool during breast cancer surgery to see if it can help doctors find lymph nodes more accurately and improve treatment for patients.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.